Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Dec;98(12):1575-1584.
doi: 10.1111/aogs.13691. Epub 2019 Aug 11.

The greater incidence of small-for-gestational-age newborns after gonadotropin-stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day

Affiliations

The greater incidence of small-for-gestational-age newborns after gonadotropin-stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day

Alexandra S Kohl Schwartz et al. Acta Obstet Gynecol Scand. 2019 Dec.

Abstract

Introduction: Reproductive scientists have postulated various risk factors for lower birthweight following conventional gonadotropin-stimulated in vitro fertilization compared with spontaneously conceived children: parental factors (age, health, duration of subfertility and smoking habits); ovarian stimulation; laboratory procedures; the number of oocytes retrieved and the number of embryos transferred. Our aim was to investigate the impact of gonadotropin stimulation and serum estradiol level on the risk of a newborn being small-for-gestational-age.

Material and methods: We conducted a cohort study (2010-2016) of singletons (n = 155) born either after conventional gonadotropin-stimulated in vitro fertilization (using ≥150 IU/d human gonadotropin for stimulation) or after natural cycle in vitro fertilization without any stimulation. We analyzed perinatal outcomes using birthweight percentiles, adjusted for gestational age and sex.

Results: The proportion of small-for-gestational-age was 11.8% following conventional gonadotropin-stimulated in vitro fertilization and 2.9% after natural cycle in vitro fertilization (P = 0.058). The odds of small-for-gestational-age were significantly higher with supraphysiological estradiol levels in maternal serum on ovulation trigger day (unadjusted odds ratio 4.58; 95% confidence interval 1.35-15.55; P = 0.015). It remained significant after adjusting for maternal height, age and body mass index (adjusted odds ratio 3.83; 95% confidence interval 1.06-13.82; P = 0.041).

Conclusions: We found an associated risk of children being born small-for-gestational-age after conventional gonadotropin-stimulated in vitro fertilization compared with natural cycle in vitro fertilization. This higher risk is significantly associated with supraphysiological estradiol levels. We propose a reduction in the dosage of gonadotropin to minimize the risk of small-for-gestational-age and future health consequences.

Keywords: gonadotropin; high-risk pregnancy; in vitro fertilization; infertility; pregnancy; reproductive endocrinology.

PubMed Disclaimer

Conflict of interest statement

The authors have stated explicitly that there are no conflicts of interest in connection with this article.

Figures

Figure 1
Figure 1
Boxplot of birthweight percentiles of conventional gonadotropin‐stimulated in vitro fertilization (c‐IVF) vs natural cycle in vitro fertilization (NCIVF) [Color figure can be viewed at http://www.wileyonlinelibrary.com]
Figure 2
Figure 2
Boxplot of birthweight percentiles estradiol (E2) level <10 000 pmol/L vs ≥10 000 pmol/L E2 level [Color figure can be viewed at http://www.wileyonlinelibrary.com]
Figure 3
Figure 3
Birthweight percentile with higher estradiol (E2) level (in maternal serum, pmol/L) on ovulation trigger day in natural cycle in vitro fertilization [Color figure can be viewed at http://www.wileyonlinelibrary.com]
Figure 4
Figure 4
Birthweight percentile with higher estradiol (E2) level (in maternal serum, pmol/L) on ovulation trigger day in conventional gonadotropin‐stimulated in vitro fertilization [Color figure can be viewed at http://www.wileyonlinelibrary.com]

References

    1. Pandey S, Shetty A, Hamilton M, Bhattacharya S, Maheshwari A. Obstetric and perinatal outcomes in singleton pregnancies resulting from IVF/ICSI: a systematic review and meta‐analysis. Hum Reprod Update. 2012;18:485‐503. - PubMed
    1. Pinborg A, Wennerholm UB, Romundstad LB, et al. Why do singletons conceived after assisted reproduction technology have adverse perinatal outcome? Systematic review and meta‐analysis. Hum Reprod Update. 2013;19:87‐104. - PubMed
    1. Berntsen S, Söderström‐Anttila V, Wennerholm U‐B, et al. The health of children conceived by ART: “the chicken or the egg?”. Hum Reprod Update. 2019;25:137‐158. - PubMed
    1. Davies MJ, Moore VM, Willson KJ, et al. Reproductive technologies and the risk of birth defects. N Engl J Med. 2012;366:1803‐1813. - PubMed
    1. Kleijkers SHM, Van Montfoort APA, Smits LJM, et al. IVF culture medium affects post‐natal weight in humans during the first 2 years of life. Hum Reprod. 2014;29:661‐669. - PubMed

Publication types